AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04217252 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: PMseqTM high-throughput sequencing technology
Description: high throughput sequencing of infectious pathogens
Study NCT05587166 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: ultrasound guided adductor canal block
Description: ultrasound-guided adductor canal block using oblique short-axis for catheter insertion
Study NCT05277038 — intervention group
Intervention type: DRUG
Intervention: Clonidine 0.1mg pill
Description: Routine prescription for insomnia
Study NCT05277038 — intervention group
Intervention type: DRUG
Intervention: Clonidine 0.2mg pill
Description: Routine prescription for insomnia
Study NCT05277038 — intervention group
Intervention type: DRUG
Intervention: Zopiclone 3.75mg pill
Description: Routine prescription for insomnia
Study NCT05277038 — intervention group
Intervention type: DRUG
Intervention: Zopiclone 7.5mg pill
Description: Routine prescription for insomnia
Study NCT05568550 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Pembrolizumab will be delivered via IV at 200mg on day 1 of each 3-week cycle for approximately 12 months. Cycle 1 begins 21 days prior to radiation therapy and cycles 2-17 are administered during and after radiation therapy.
Study NCT05284669 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental e-learning
Description: Interactive lecture based on the guidelines for the management of LBP with a focus on self-management and patient's reassurance
Study NCT05284669 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Traditional e-learning
Description: Traditional lecture based on the guidelines for the management of LBP with a focus on diagnostic triage and specific cause of LBP
Study NCT04305340 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Myant SKIIN Device
Description: 1. Supine position: Participant lays on a bed on their back for 5 minutes~2. Sitting position: Participant sits on a chair for 5 minutes~3. Standing position: Participant stands for 5 minutes.~4. Exercise measurement: treadmill exercise test - the protocol entails increases of 0.5 mph every minute with zero change in the incline. Starting point would 1.5 mph. The test will be interrupted if the target heart rate of 190 beats per minute is reached or if symptoms and/or arrhythmias and ST depression would be observed. Patient will be monitor during recovery for 5 minutes.~5. Cool-down: Participants cool-down for 5 minutes
Study NCT05568550 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Olaparib
Description: 200mg Olaparib will be given twice daily for a total of 3 cycles. Cycle 1 begins 21-days prior to radiation therapy.
Study NCT05568550 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Androgen Deprivation Therapy
Description: Androgen Deprivation Therapy (either LHRH agonist or LHRH antagonist) as per treating physician choice will be allowed within 3 months prior to randomization. Duration is per institutional standards.
Study NCT05568550 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation Therapy
Description: Definitive radiation (total dose and fractions) will be dosed per institutional standards. Definitive radiation may include external beam radiation therapy with or without brachytherapy, based on NCCN risk score and as per treating physicians.
Study NCT05440318 — intervention group
Intervention type: DEVICE
Intervention: Wireless wearable digital devices
Description: Wireless wearable digital devices (including a small patch, modified watch, and datahub smartphone with electronic Patient Reported Outcomes \[ePRO\] capability) will be provided to each participant enrolled in the study.
Study NCT05477199 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral principles-based treatment program
Description: The treatment protocol had a total duration of 6 weeks. Two sessions were conducted each week, the first being a group session lasting 1.5 hours and the second an individual session lasting 45 minutes. During the group sessions, emotional disclosure and sharing of the experiences of patients with post COVID-19 syndrome were encouraged. During the individual sessions, a strong relationship was developed between the patient and the healthcare professional, with the healthcare professional helping the patient develop self-efficacy, thought monitoring, helpful self-talk, and reflection on changes in activity levels throughout the program.
Study NCT05477199 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control intervention
Description: Patients received an informational brochure in a consultation with a health professional. The brochure explained the importance of physical activity to improve the health condition of these patients. Patients had the opportunity to ask any questions to the healthcare professional.
Study NCT06252441 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rectal Diclofenac
Description: 100 mg Rectal Diclofenac Before ERCP
Study NCT06252441 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oral N-acetyl cysteine
Description: 1200 mg N-acetyl cysteine in 150 cc water orally before ERCP.
Study NCT05823272 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ONS
Description: oral nutritional supplement
Study NCT04454944 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: LPG subsidy
Description: Different subsidy rates, ranging between 0% and 100% (listed below) will be written on cards. Individuals will randomly select a card to display the subsidy rate for each household. The card will be concealed with a scratch-off sticker, with a higher likelihood of drawing a high price (low subsidy) than a low price (high subsidy) given that take up will be higher in the latter group.
Study NCT04454944 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Distance allocation
Description: We will set up fuel supply depots to increase the convenience and lower costs and hassle associated with traveling to an established filling station. The supply depots will mirror a recirculation model of LPG distribution currently being piloted by the National Petroleum Authority of Ghana. Households will be randomly assigned to one of the supply depots in advance or to continue refilling their cylinder at the filling station.
Study NCT04714021 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CO2
Description: to insufflate CO2 into the stomach instead of air during the PEG
Study NCT04714021 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: air
Description: to insufflate air into the stomach instead of CO2 during the PEG
Study NCT05288049 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Enhancing cognitive reserve
Description: The CR enhancement protocol consists of 12 weekly sessions in a group format with audiovisual and technological devices support. All sessions are held separately for parents and children, adolescents and young adults. All material is adapted to different ranges of age. This same protocol will be adapted for patients with a first affective or non-affective episode. Two sessions are about to promote healthy lifestyle by implementing healthy habits, two more sessions about training and practice mindfulness with virtual reality devices, two sessions about improving leisure-time activities, focused on promoting of intellectual and/or cultural activities as leisure time as well as physical exercise, the rest of sessions are about to promote vocational and educational activities, metacognition, social skills, problem-solving techniques and how to detect and act on warning signs, a brief psychoeducative session about the main early warning signs of general psychopathology.
Study NCT05288049 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Support therapy
Description: The support control group will have weekly meetings with assistants to talk about the difficulties they had during the week, without receiving a specific intervention.
Study NCT04898036 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Blue Light Therapy
Description: This phototherapy device (PTD-1) consists of a Plexiglas hand compartment (cleanable) enclosed in a powder-coated steel cabinet. Within the cabinet are two blue LED panels located above and below the hand compartment to illuminate the hands.
Study NCT04898036 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sham Light Therapy
Description: To turn the device into a sham mode, a thin opaque liner can be inserted which will block light from illuminating the hands.
Study NCT05826899 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: 54Fe SO4
Description: 4 mg of iron as FeSO4 labelled with 4 mg of 54Fe
Study NCT05826899 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: 57Fe Oat-1
Description: 4 mg of iron as 0.46 g Fe-oat 1 (Oat fibrils, ascorbic acid reduced) labelled with 57Fe
Study NCT05691400 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Palbociclib 125Mg Tab
Description: 125 mg single dose
Study NCT05498116 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Montelukast
Description: 10mg daily
Study NCT05498116 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 1 capsule daily
Study NCT06253624 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: All Arthroscopic ATFL Repair Surgery
Description: The patients undergo surgery with spinal block, general anesthesia, or a combination of both. During the diagnostic arthroscopy, the anterior compartment is examined with a 4 mm 30-degree camera, and lateral ankle instability is diagnosed arthroscopically
Study NCT05257369 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Blue-Green LED photoherapy
Description: Continuous phototherapy for 24 h, for newborns placed incubators or radiant warmers will interrupted only for feeding and nursing for 20 - 30 min every three hours.
Study NCT05257369 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Blue-Green LED photoherapy
Description: Continuous phototherapy for 24 h, for newborns placed incubators or radiant warmers will interrupted only for feeding and nursing for 20 - 30 min every three hours.
Study NCT05826899 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: 58Fe Oat-2
Description: 4 mg of iron as 0.46 g Fe-Oat 2 (Fe-Oat with NaOH) labelled with 58Fe.
Study NCT05826899 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: 54 FeSO4 + Acai puree with honey
Description: 4 mg of iron as FeSO4 labelled with 4 mg of 54Fe given with 30 mL acai puree with honey.
Study NCT05691400 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ribociclib 200Mg Oral Tablet
Description: 200 mg single dose
Study NCT05691400 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Abemaciclib 150 MG Oral Tablet
Description: 150 mg single dose
Study NCT05815017 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Yoomi Physical Therapy Software
Description: Physical Therapy software via a computer/monitor will be set up for the patient. It will begin with a tutorial video for different exercises in the form of games and then ask patients to perform in sequence with prompting and motion tracking. Exercises include Frontal Bicep Curls, Arm Crosses, Press Ups, Arm Rotations, and Basketball Shots.
Study NCT06198166 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cuevas Medek
Description: Group A: will receive Cuevas Medek (CME) In a following procedure: supporting the patient in balance at the leg level and with slight posterior support. Then, once kept in the air for few seconds, slight up and down oscillations will make. The materials that will be used consists of three wooden boxes with the same dimensions (20cm x 40cm x 60cm), a bigger box, a wooden plate and two planks with the same dimensions (17cm x 80cm). Boxes
Study NCT06198166 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard kinetic programs
Description: Group B: will receive standard kinetic programs consisting of stretching (2 sets 15 repetitions with 5 seconds hold) , passive mobilizations (2 sets of 20 repetitions), orthosis( for 6 hours). These techniques and orthotics devices typically focus on tight muscles, maintain proper foot alignment and to address sensory processing difficulties and promote relaxation. Stretching will focus on the hamstrings and calf muscles tightness.
Study NCT05125965 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: additional time for the MRI
Description: 3 additional minutes to perform the MRI
Study NCT05223140 — intervention group
Intervention type: BEHAVIORAL
Intervention: Birth within 7 minutes of rumping
Description: Birth within 7 minutes of rumping (+3 station), within 5 minutes of birth of pelvis, within 3 minutes of birth of umbilicus
Study NCT05223140 — intervention group
Intervention type: BEHAVIORAL
Intervention: Premature cord clamping
Description: Umbilical cord clamping \<1 minute following birth
Study NCT05531110 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cataract surgery with insertion of Eyhance ICB00
Description: Cataract surgery with insertion of Eyhance ICB00
Study NCT04856098 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Indacaterol maleate and glycopyrronium bromide
Description: Batch A Ultibro Breezhaler 85/43 μg 2 capsules
Study NCT04856098 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Indacaterol maleate and glycopyrronium bromide
Description: Batch A Ultibro Breezhaler 85/43 μg 1 capsule
Study NCT04856098 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Indacaterol maleate and glycopyrronium bromide
Description: Batch B Ultibro Breezhaler 85/43 μg 2 capsules
Study NCT04856098 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ultibro Breezhaler with oral charcoal
Description: Activated charcoal suspension, granules 50 g / bottle
Study NCT05826899 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: 57Fe Oat-1 + Acai puree with honey
Description: 4 mg of iron as 0.46 g Fe-oat 1 (Oat fibrils, ascorbic acid reduced) labelled with 57Fe given with 30 mL acai puree with honey.
Study NCT05531110 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Cataract surgery with insertion of Alcon SN60WF
Description: Cataract surgery with insertion of Alcon SN60WF
Study NCT06454097 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Assess the response glioma to radiochemotherapy using radiogenomics-based AI model
Description: Predict the radiochemotherapy sensitivity of patients with glioma using an established radiogenomics-based artificial intellegent mode
Study NCT05717465 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Anatomy diagrams
Description: The visual aids used included:~* An anatomical diagram illustrating how a lumbar puncture is carried out~* Paling palette, diagram illustrating the number of individuals affected by a particular condition~* Paling perspective scale, diagram comparing the risk of an event occurring in comparison to other 'everyday' risks
Study NCT05717465 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard informed consent
Description: Audio narration of a video containing text information relating to the lumbar puncture procedure (including risks) and an image of a consent form
Study NCT05717465 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard informed consent
Description: Audio narration of a video containing text information relating to the lumbar puncture procedure (including risks) and an image of a consent form
Study NCT05826899 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: 58Fe Oat-2 + Acai puree with honey
Description: 4 mg of iron as 0.46 g Fe-Oat 2 (Fe-Oat with NaOH) labelled with 58Fe given with 30 mL acai puree with honey
Study NCT05610423 — intervention group
Intervention type: OTHER
Intervention: no intervention
Description: No intervention. Observational study only
Study NCT05038111 — intervention group
Intervention type: DRUG
Intervention: Dexmedetomidine
Description: perioperative dexmedetomidine infusion
Study NCT05293821 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: TriQuik IVD
Description: TriQuik Invitro Diagnostic Device Cassettes. TriQuik Invitro Diagnostic Device Cassettes.
Study NCT06340490 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: RJMty19 (CD19-CAR-DNT cells)
Description: Lentiviral vector-transducted double negative T cells (DNT) to express anti-CD19 CAR. Prior to cellular infusion, each patient received cyclophosphamide and fludarabine lymphodepleting chemotherapy.
Study NCT06542991 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: transcranial magnetic stimulation
Description: During treatment, the patient underwent cTBS targeting the left SMA for 7 consecutive days. Each treatment day comprised six rounds of cTBS, with a 15-minute interval between each. A single cTBS session involved trains of three pulses at 50 Hz, repeated every 200 ms (5 Hz), until reaching a total of 600 pulses, lasting 40s. Stimulation intensity remained at 80% of resting motor threshold. In total, patients received 25,200 pulses throughout the treatment period.
Study NCT04435015 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Camostat Mesylate
Description: Participants will be given Camostat mesylate three times daily.
Study NCT04435015 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Microcrystalline Cellulose, NF
Description: Participants will be given Microcrystalline Cellulose (placebo) three times daily.
Study NCT06390345 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: FOCuSEd Integrated Intervention
Description: Participants randomized to the intervention will receive an integrated telehealth-delivered, remote lifestyle intervention that promotes healthy eating and 150 minutes per week of moderate-intensity physical exercise. This intervention will include a core curriculum during the first 3 months that includes: 1) a 12-session video based program; 2) goal setting and self-monitoring using a Fitbit tracker and MyFitnessPal; 3) lifestyle coaching; and 4) three tele-pulmonary rehab sessions and an additional 60-75 minutes of gradually increasing self-directed exercise per week. At the end of 3 months, we will offer to enter a recommendation for weight loss medications to intervention participants with a BMI of ≥ 27 kg/m2. In the post-core period (months 4-12), participants will continue to have as-needed access to the lifestyle coach.
Study NCT06390345 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Enhanced Usual Care
Description: Participants in the enhanced usual care group will be referred to MOVE! (VA's weight loss management program) and pulmonary rehabilitation in coordination with their primary care provider.
Study NCT06165978 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-monitoring
Description: pedometer/activity band provided to each participant
Study NCT06165978 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Goal setting and review
Description: Goal setting and review (weekly: +15% of the previous week's average daily steps or walking time, or +1000 steps/day or +10 minutes walking - to be specified)
Study NCT06165978 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Education
Description: Educational sessions (face-to-face: providing a manual/explanatory brochure of the intervention; remote: addressing symptom pathophysiology, symptom management, among other topics)
Study NCT06165978 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Feedback
Description: Daily or weekly feedback for patients (emotional/social support)
Study NCT06165978 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Contact
Description: Contact with patients (face-to-face: for assessments; on remote: 1 -messages: for therapists' daily/weekly feedback or patient reports; 2 - calls: to adjust weekly goals or address doubts or issues)
Study NCT06165978 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Exercise based on patient preference, explaining how to identify moderate intensity (HRmax=64-76%, Borg 3-6) or vigorous intensity (HRmax=77-95%; Borg 7-8) and monitoring safety parameters (StO2>88%, HRmax\<96%, Borg\<9)
Study NCT06523062 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: blood pressure measurement
Description: automated blood pressure measurement on 3 occasions at each consultation, twice with one month apart
Study NCT06280885 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Participants will be randomised to either the FIERCE exercise programme involving supervised exercise prescription
Study NCT06280885 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Health Behaviour Change (Pedometer)
Description: Participants in both arms will be provided with a pedometer as a health behaviour change intervention
Study NCT05982054 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: core decompression with local bone marrow mononuclear cells injection
Description: under local anesthesia ,anterior approach, with ultrasound and fluoroscopy guide
Study NCT05623267 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sugemalimab
Description: Recombinant anti-PD-L1 fully human monoclonal antibody
Study NCT05623267 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo of Sugemalimab
Study NCT06133192 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Uvadex
Description: Uvadex use for ECP
Study NCT06133192 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Steroids
Description: steroids 2 mg/kg/d